Benign neuroendocrine tumors
ICD-10 Codes (0)
No codes found matching your search
Updates & Changes
FY 2026 Updates
Deleted Codes
No codes deleted in this range for FY 2026
No significant changes for FY 2026
This range maintains stability with current coding practices
Historical Changes
- •FY 2025: Routine maintenance updates with minor terminology clarifications
- •FY 2024: Enhanced specificity requirements for certain code ranges
- •FY 2023: Updated documentation guidelines for improved clarity
Upcoming Changes
- •Proposed updates pending review by Coordination and Maintenance Committee
- •Under consideration: Enhanced digital health integration codes
Implementation Guidance
- •Review all FY 2026 updates for D3A-D3A codes before implementation
- •Always verify the most current codes in the ICD-10-CM manual
- •Ensure clinical documentation supports the selected diagnosis codes
- +3 more guidance items...
Range Overview
The D3A-D3A range in the ICD-10 coding system is dedicated to benign neuroendocrine tumors. These codes are used to document diagnoses of non-cancerous tumors that originate in the body's neuroendocrine system, which includes glands such as the pituitary, adrenal, and thyroid. The codes in this range are specific to the location of the tumor, allowing for detailed documentation of the patient's condition.
Key Usage Points:
- •Always verify the location of the tumor before selecting a code from this range.
- •Use additional codes to document any associated endocrine disorders or complications.
- •Remember that these codes are for benign tumors only; malignant neuroendocrine tumors have a different code range.
- •Always check the patient's medical record for any changes in the status of the tumor.
- •Use the appropriate code for unspecified neuroendocrine tumor if the location is not documented.
Coding Guidelines
When to Use:
- ✓When a patient has been diagnosed with a benign neuroendocrine tumor.
- ✓When a patient's benign neuroendocrine tumor has been removed but they are still receiving follow-up care.
- ✓When a patient has a history of benign neuroendocrine tumors.
- ✓When a benign neuroendocrine tumor is found incidentally during an examination or procedure for another condition.
When NOT to Use:
- ✗When the tumor is malignant or of uncertain behavior.
- ✗When the tumor is not located in the neuroendocrine system.
- ✗When the patient has a neuroendocrine disorder but no tumor.
- ✗When the patient has a history of neuroendocrine tumors but no current diagnosis.
Code Exclusions
Always verify the behavior of the tumor and the presence of a neuroendocrine disorder before selecting a code.
Documentation Requirements
Documentation for benign neuroendocrine tumors should include the location of the tumor, its behavior, and any associated endocrine disorders or complications. The patient's history of neuroendocrine tumors should also be documented.
Clinical Information:
- •Location of the tumor
- •Behavior of the tumor
- •Associated endocrine disorders or complications
- •Patient's history of neuroendocrine tumors
Supporting Evidence:
- •Pathology reports
- •Imaging studies
- •Surgical reports
- •Clinical notes
Good Documentation Example:
Patient has a benign neuroendocrine tumor in the adrenal gland. Pathology report confirms benign behavior. Patient has a history of similar tumors.
Poor Documentation Example:
Patient has a neuroendocrine tumor.
Common Documentation Errors:
- ⚠Failing to document the location of the tumor
- ⚠Failing to document the behavior of the tumor
- ⚠Failing to document associated endocrine disorders or complications
- ⚠Failing to document the patient's history of neuroendocrine tumors
Range Statistics
Coding Complexity
The coding complexity for the D3A-D3A range is medium due to the need to accurately determine the location and behavior of the tumor, identify any associated endocrine disorders or complications, and document the patient's history of neuroendocrine tumors. These factors require a thorough understanding of the neuroendocrine system and the ability to interpret complex clinical information.
Key Factors:
- ▸Determining the location of the tumor
- ▸Determining the behavior of the tumor
- ▸Identifying associated endocrine disorders or complications
- ▸Documenting the patient's history of neuroendocrine tumors
Specialty Focus
The D3A-D3A range is primarily used by endocrinologists and oncologists. It may also be used by general practitioners and other specialists who encounter patients with benign neuroendocrine tumors.
Primary Specialties:
Clinical Scenarios:
- • A patient presents with symptoms of an adrenal disorder. Imaging studies reveal a benign neuroendocrine tumor in the adrenal gland.
- • A patient with a history of benign neuroendocrine tumors presents for a routine follow-up examination.
- • A patient undergoes surgery for a suspected malignant tumor, which is later determined to be a benign neuroendocrine tumor.
- • A patient is found to have a benign neuroendocrine tumor during an examination for another condition.
Resources & References
Resources for the D3A-D3A range include the official ICD-10 coding guidelines, clinical references on neuroendocrine tumors, and educational materials on medical coding.
Official Guidelines:
- ICD-10-CM Official Guidelines for Coding and Reporting
- World Health Organization's International Classification of Diseases
- American Health Information Management Association's Coding Clinic
Clinical References:
- National Cancer Institute's information on neuroendocrine tumors
- American Society of Clinical Oncology's guidelines on neuroendocrine tumors
Educational Materials:
- American Academy of Professional Coders' ICD-10 training materials
- American Health Information Management Association's coding education resources
Frequently Asked Questions
How do I code for a benign neuroendocrine tumor with an associated endocrine disorder?
First, select the appropriate code from the D3A-D3A range for the tumor. Then, use an additional code to document the endocrine disorder.